A314140 Stock Overview
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
RP Bio Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩7,910.00 |
| 52 Week High | ₩11,330.00 |
| 52 Week Low | ₩7,190.00 |
| Beta | 0 |
| 11 Month Change | -2.59% |
| 3 Month Change | -18.62% |
| 1 Year Change | -26.76% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.78% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| A314140 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.2% | 3.4% | 1.3% |
| 1Y | -26.8% | 9.5% | 5.8% |
Return vs Industry: A314140 underperformed the KR Pharmaceuticals industry which returned 9.5% over the past year.
Return vs Market: A314140 underperformed the KR Market which returned 5.8% over the past year.
Price Volatility
| A314140 volatility | |
|---|---|
| A314140 Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A314140's share price has been volatile over the past 3 months.
Volatility Over Time: A314140's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | n/a | www.rpcorp.co.kr |
RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, and chewable soft capsules; non-synthetic and chewable tablets; hard capsules and jelly sticks; and granule, effervescent granule, and stick type capsule powders. The company was founded in 1983 and is based in Seoul, South Korea.
RP Bio Inc. Fundamentals Summary
| A314140 fundamental statistics | |
|---|---|
| Market cap | ₩68.55b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A314140 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A314140 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A314140 perform over the long term?
See historical performance and comparison